How have NEXI shares performed in 2024?

NexImmune's stock was trading at $2.22 on January 1st, 2024. Since then, NEXI stock has increased by 46.4% and is now trading at $3.25. View the best growth stocks for 2024 here .

Are investors shorting NexImmune?

NexImmune saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 17,800 shares, a decrease of 49.4% from the March 15th total of 35,200 shares. Based on an average trading volume of 1,160,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 2.3% of the company's shares are short sold. View NexImmune's Short Interest .

When is NexImmune's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NEXI earnings forecast .

How were NexImmune's earnings last quarter?

NexImmune, Inc. (NASDAQ:NEXI) released its earnings results on Friday, November, 12th. The company reported ($16.25) EPS for the quarter, topping analysts' consensus estimates of ($16.75) by $0.50.

When did NexImmune's stock split?

NexImmune's stock reverse split before market open on Thursday, October 19th 2023. The 1-25 reverse split was announced on Wednesday, October 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

When did NexImmune IPO?

NexImmune (NEXI) raised $75 million in an initial public offering on Friday, February 12th 2021. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. Barclays, Cantor, Raymond James and Allen & Co. acted as the underwriters for the IPO.

How do I buy shares of NexImmune?

Shares of NEXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NEXI

NexImmune (NEXI) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free NEXI Stock Alerts

$3.25

-0.05 (-1.52%)

(As of 10:46 AM ET)

Compare

Today's Range: $3.06
▼
$3.29
50-Day Range: $3.15
▼
$9.94
52-Week Range: $1.25
▼
$28.69

Volume: 11,834 shs
Average Volume: 1.82 million shs
Market Capitalization: $4.45 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get NexImmune alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About NexImmune Stock (NASDAQ:NEXI)

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

NEXI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NEXI Stock News Headlines

April 17, 2024 | investorplace.com

NEXI Stock Earnings: NexImmune Reported Results for Q4 2023

April 16, 2024 | theglobeandmail.com

Acute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsight

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 15, 2024 | msn.com

Portage mulls company closure, pauses enrolment for lead clinical programme

April 11, 2024 | americanbankingnews.com

Short Interest in NexImmune, Inc. (NASDAQ:NEXI) Decreases By 49.4%

April 2, 2024 | msn.com

Xilio fires 21% of its workforce and reprioritises pipeline

February 7, 2024 | msn.com

NexImmune Announces New Offerings in Recent Press Release

February 6, 2024 | markets.businessinsider.com

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 6, 2024 | msn.com

NexImmune Secures Funding Through Equity and Warrant Sales

February 3, 2024 | msn.com

NexImmune Ends Stock Sale Agreement, Raises $5.1 Million

February 2, 2024 | msn.com

NexImmune slips after securities offering

February 2, 2024 | finance.yahoo.com

NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

January 13, 2024 | nasdaq.com

NexImmune, Inc. Common Stock (NEXI)

January 9, 2024 | investorplace.com

NexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidation

December 26, 2023 | bizjournals.com

NexImmune's future in limbo as Gaithersburg biotech extends liquidation vote

December 10, 2023 | ca.finance.yahoo.com

NexImmune, Inc. (NEXI) Stock Price, News, Quote & History - Yahoo Finance

December 1, 2023 | investorplace.com

NEXI Stock Halted: What’s Going on With NexImmune Shares Today?

December 1, 2023 | investorplace.com

Why Is NexImmune (NEXI) Stock Up 353% Today?

November 23, 2023 | morningstar.com

NexImmune Inc Ordinary Shares NEXI

November 8, 2023 | bizjournals.com

Gaithersburg’s NexImmune prepares to shut down, lay off ‘substantially all’ employees

November 6, 2023 | msn.com

What's Going On With Neximmune (NEXI) Stock Monday?

November 3, 2023 | msn.com

Why Neximmune (NEXI) Stock Is Getting Hammered

November 3, 2023 | marketwatch.com

NexImmune Shares Slide Premarket as Biotech Says It Will Liquidate

October 24, 2023 | finance.yahoo.com

NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes

October 19, 2023 | finance.yahoo.com

NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting

October 18, 2023 | finanznachrichten.de

NexImmune, Inc.: NexImmune Announces 1-for-25 Reverse Stock Split

See More Headlines

Receive NEXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/12/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:NEXI
CUSIP: N/A
CIK: 1538210
Web: www.neximmune.com
Phone: 301-825-9810
Fax: N/A
Employees: 22
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($30.89)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-62,510,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -216.33%
Return on Assets: -157.05%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.66
Quick Ratio: 1.66

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $33.43 per share
Price / Book: 0.10

Miscellaneous

Outstanding Shares: 1,060,000
Free Float: 853,000
Market Cap: $3.49 million
Optionable: Not Optionable
Beta: 1.84

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Ms. Kristi Jones R.Ph. (Age 61)
CEO, President & Director
Comp: $680.44k
Dr. Mathias Oelke Ph.D. (Age 55)
Chief Scientific Officer
Comp: $621.26k
Mr. John Trainer M.B.A. (Age 50)
Consultant
Comp: $546.13k
Dr. Jerome Bernard Zeldis M.D. (Age 74)
Ph.D., Consultant
Comp: $618.2k
Mr. Timothy Stover
VP, Corporate Controller and Principal Financial & Accounting Officer
Mr. Karen Haslbeck
Head of Human Resources
Dr. Daniel P. Bednarik
Senior Vice President of Molecular Engineering & Protein Design
Dr. Robert Douglas Knight M.D. (Age 73)
Chief Medical Officer
Comp: $454.77k
Mr. Chad Rubin
Senior Vice President of Corporate Affairs
Dr. Jack A. Ragheb M.D.
Ph.D., Senior Vice President of Translational Science

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NEXI Stock Analysis - Frequently Asked Questions

How have NEXI shares performed in 2024?: NexImmune's stock was trading at $2.22 on January 1st, 2024. Since then, NEXI stock has increased by 46.4% and is now trading at $3.25.
View the best growth stocks for 2024 here.
Are investors shorting NexImmune?: NexImmune saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 17,800 shares, a decrease of 49.4% from the March 15th total of 35,200 shares. Based on an average trading volume of 1,160,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 2.3% of the company's shares are short sold.
View NexImmune's Short Interest.
When is NexImmune's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NEXI earnings forecast.
How were NexImmune's earnings last quarter?: NexImmune, Inc. (NASDAQ:NEXI) released its earnings results on Friday, November, 12th. The company reported ($16.25) EPS for the quarter, topping analysts' consensus estimates of ($16.75) by $0.50.

When did NexImmune's stock split?: NexImmune's stock reverse split before market open on Thursday, October 19th 2023. The 1-25 reverse split was announced on Wednesday, October 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.
When did NexImmune IPO?: NexImmune (NEXI) raised $75 million in an initial public offering on Friday, February 12th 2021. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. Barclays, Cantor, Raymond James and Allen & Co. acted as the underwriters for the IPO.
How do I buy shares of NexImmune?: Shares of NEXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NEXI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

NexImmune (NEXI) Stock Price, News & Analysis

About NexImmune Stock (NASDAQ:NEXI)

NEXI Stock Price History

NEXI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

NEXI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info